Article
Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Apr 2003
Dey Swatee, Spring Paul M, Arnold Suzanne, Valentino Joseph, Chendil Damodaran, Regine William F, Mohiuddin Mohammed, Ahmed Mansoor M
Abstract excerpt
This study was designed to: (a) evaluate the induction of hyper-radiation sensitivity (HRS), a phenomenon observed at low doses of radiation (<1 Gy); (b) compare the potentiating effects of single dose radiation (2 Gy) versus the effect of low-dose fractionated radiation (LDFRT; <1 Gy) on Paclitaxel; and (c) understand the molecular mechanism of LDFRT-mediated chemo-potentiating effects, in wild-type p53 SCC-61...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
